CK-MB - THE MB ISOENZYME OF CREATINE KINASE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2015-10-01 for CK-MB - THE MB ISOENZYME OF CREATINE KINASE manufactured by Roche Diagnostics.

Event Text Entries

[27204300] This event occurred in (b)(6). A patient (b)(6) was also provided. A clarification has been requested. (b)(6) was also provided.
Patient Sequence No: 1, Text Type: N, H10


[27204301] The customer reported that the values of the troponin t hs (high sensitive) stat (short turn around time) - tnt test were too high in contrast to the clinical status of one patient. The patient was subjected to an electric shock, but is currently in good condition. The patient's ecg was normal, the blood pressure was normal, and other clinical signs were also ok. The ck-mb - the mb isoenzyme of creatine kinase (ckmb) test results of the patient were also said to be elevated. The test results were measured on an e601 analyzer. The patient's samples were suspected of containing an interference to the assays. This medwatch will cover ckmb. Please refer to the medwatch with (b)(6) for information related to the tnt assay. The tnt assay was measured 4 times upon admission of the patient, on (b)(6) 2015. The values were said to be "between 41 to 48" ng/l. The ckmb results of the patient were also said to be increased upon admission, with a values of 12. 1 ug/l on (b)(6) 2015. The ckmb values then decreased to 5. 5 ug/l on (b)(6) 2015. The n-terminal pro b-type natriuretic peptide (bnp) was said to be slightly elevated on (b)(6) 2015, with a value of 135 pg/ml. The patient was hospitalized for six days for observation in the icu based on the tnt and ckmb results, but was not adversely affected. The e601 analyzer serial number was (b)(4). Preliminary investigations have determined that an electrical shock is an event that is expected to have an impact on cardiac tissue. Therefore, elevated cardiac markers should be expected, too.
Patient Sequence No: 1, Text Type: D, B5


[28343666] A sample from the patient was provided for investigation and the customer's results could be confirmed. The date of birth on medwatch field a2 has been updated.
Patient Sequence No: 1, Text Type: N, H10


[30737935] A specific root cause for the difference in ck-mb values could not be determined based on the provided information.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2015-04257
MDR Report Key5116171
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2015-10-01
Date of Report2015-11-09
Date of Event2015-08-12
Date Mfgr Received2015-09-08
Date Added to Maude2015-10-01
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameCK-MB - THE MB ISOENZYME OF CREATINE KINASE
Generic NameCOLORIMETRIC METHOD, CPK OR ISOENZYMES
Product CodeJHY
Date Received2015-10-01
Model NumberNA
Catalog NumberASKU
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2015-10-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.